CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 73 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,315,000 | -38.9% | 550,000 | 0.0% | 0.27% | -47.2% |
| Q4 2017 | $2,151,000 | +133.6% | 550,000 | +46.3% | 0.50% | +33.7% |
| Q4 2015 | $921,000 | -12.3% | 376,000 | +7.4% | 0.38% | -20.3% |
| Q3 2015 | $1,050,000 | +41.3% | 350,000 | +40.0% | 0.47% | +32.5% |
| Q4 2014 | $743,000 | -32.8% | 250,000 | -42.8% | 0.36% | -54.2% |
| Q2 2014 | $1,106,000 | +144.7% | 437,296 | +118.6% | 0.78% | +191.0% |
| Q1 2014 | $452,000 | +32.6% | 200,000 | +14.3% | 0.27% | +27.6% |
| Q4 2013 | $341,000 | – | 175,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |